A recent study suggests that a decline in the sense of smell may be an early warning sign of Alzheimer's disease [1].
This finding is significant because it offers a potential pathway toward a simple and inexpensive method for early detection. Identifying the disease before the onset of memory loss could allow for earlier intervention and management of the condition [1, 2].
Dr. Callen Giddam, a consultant in neurology, neurocritical care, and epilepsy, said these findings on the "Health First" program on France 24 Arabic [1]. The discussion focused on how olfactory dysfunction often precedes the cognitive decline typically associated with the disease [1].
Researchers are examining the possibility of using smell tests as a screening tool. Because these tests are non-invasive and cost-effective, they could be deployed more widely than complex imaging or spinal fluid tests to identify at-risk individuals [1, 2].
The study highlights the connection between the olfactory system and the brain regions first affected by Alzheimer's. This biological link explains why a diminished ability to identify scents often appears years before a patient experiences significant forgetfulness [1].
“A decline in the sense of smell may be an early warning sign of Alzheimer's disease.”
The shift toward olfactory screening represents a move toward 'biomarker' detection that is accessible outside of specialized clinics. While a loss of smell is not exclusive to Alzheimer's, its presence as a precursor could allow clinicians to categorize patients into high-risk groups for more intensive monitoring long before permanent cognitive damage occurs.
